These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27110262)

  • 1. Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Rahimlou M; Yari Z; Hekmatdoost A; Alavian SM; Keshavarz SA
    Hepat Mon; 2016 Jan; 16(1):e34897. PubMed ID: 27110262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.
    Rafie R; Hosseini SA; Hajiani E; Saki Malehi A; Mard SA
    Clin Exp Gastroenterol; 2020; 13():35-45. PubMed ID: 32158249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
    Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
    Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Cheraghpour M; Imani H; Ommi S; Alavian SM; Karimi-Shahrbabak E; Hedayati M; Yari Z; Hekmatdoost A
    Phytother Res; 2019 Aug; 33(8):2118-2125. PubMed ID: 31264313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of licorice root supplementation on liver enzymes, hepatic steatosis, metabolic and oxidative stress parameters in women with nonalcoholic fatty liver disease: A randomized double-blind clinical trial.
    Rostamizadeh P; Asl SMKH; Far ZG; Ahmadijoo P; Mahmudiono T; Bokov DO; Alsaikhan F; Jannat B; Mazloom Z
    Phytother Res; 2022 Oct; 36(10):3949-3956. PubMed ID: 35785498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.
    Zhang PW; Chen FX; Li D; Ling WH; Guo HH
    Medicine (Baltimore); 2015 May; 94(20):e758. PubMed ID: 25997043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA
    J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.
    Zamani N; Shams M; Nimrouzi M; Zarshenas MM; Abolhasani Foroughi A; Fallahzadeh Abarghooei E; Fattahi MR
    Complement Ther Med; 2018 Dec; 41():118-123. PubMed ID: 30477827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA; Khan DA; Ijaz A; Khan S
    Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Zinc Supplementation on Steatosis Severity and Liver Function Enzymes in Overweight/Obese Patients with Mild to Moderate Non-alcoholic Fatty Liver Following Calorie-Restricted Diet: a Double-Blind, Randomized Placebo-Controlled Trial.
    Fathi M; Alavinejad P; Haidari Z; Amani R
    Biol Trace Elem Res; 2020 Oct; 197(2):394-404. PubMed ID: 32020523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of the effect of ginger and anti-inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial.
    Kamari N; Moradinazar M; Qasemi M; Khosravy T; Samadi M; Abdolahzad H
    Food Sci Nutr; 2023 Apr; 11(4):1846-1859. PubMed ID: 37051346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study.
    Eslamparast T; Poustchi H; Zamani F; Sharafkhah M; Malekzadeh R; Hekmatdoost A
    Am J Clin Nutr; 2014 Mar; 99(3):535-42. PubMed ID: 24401715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wheat germ improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Salehi-Sahlabadi A; Kord-Varkaneh H; Kocaadam-Bozkurt B; Seraj SS; Alavian SM; Hekmatdoost A
    Phytother Res; 2022 Nov; 36(11):4201-4209. PubMed ID: 35843540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
    Asghari S; Asghari-Jafarabadi M; Somi MH; Ghavami SM; Rafraf M
    J Am Coll Nutr; 2018; 37(3):223-233. PubMed ID: 29313746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of magnesium supplementation and weight loss on liver enzymes in patients with nonalcoholic fatty liver disease.
    Karandish M; Tamimi M; Shayesteh AA; Haghighizadeh MH; Jalali MT
    J Res Med Sci; 2013 Jul; 18(7):573-9. PubMed ID: 24516489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
    Askari F; Rashidkhani B; Hekmatdoost A
    Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease.
    Saadati S; Hatami B; Yari Z; Shahrbaf MA; Eghtesad S; Mansour A; Poustchi H; Hedayati M; Aghajanpoor-Pasha M; Sadeghi A; Hekmatdoost A
    Eur J Clin Nutr; 2019 Mar; 73(3):441-449. PubMed ID: 30610213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial.
    Darand M; Darabi Z; Yari Z; Hedayati M; Shahrbaf MA; Khoncheh A; Hosseini-Ahangar B; Alavian SM; Hekmatdoost A
    Phytother Res; 2019 Sep; 33(9):2369-2377. PubMed ID: 31293021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.